Research AppraisalRandomised Controlled Trial

Comparison of Intravascular Imaging-, Physiology-, or Angiography-Guided Approaches for Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis

Journal of the American Heart AssociationSaito, Tetsuya, Aikawa, Tadao, Kiyohara, Yuko et al.7 Apr 2026DOI

Clinical Snapshot

80CEBM
Evidence: StrongRandomised Controlled Trial

PICO Framework

P — PopulationPatients undergoing percutaneous coronary intervention (PCI) for coronary artery disease, including both acute coronary syndrome and non-acute coronary syndrome presentations
I — InterventionIntravascular imaging-guided PCI (IVUS, OCT/OFDI) or physiology-guided PCI (FFR, angiography-derived FFR, instantaneous wave-free ratio)
C — ComparatorAngiography-guided PCI or comparison between different guidance modalities
O — OutcomesPrimary: trial-defined major adverse cardiovascular events (MACE). Secondary outcomes likely included individual cardiovascular endpoints

Bottom Line

This comprehensive network meta-analysis of 43 RCTs involving nearly 40,000 patients provides strong evidence that intravascular imaging-guided PCI (IVUS and OCT) significantly reduces major adverse cardiovascular events compared to conventional angiography guidance, with IVUS showing the greatest benefit (31% risk reduction). Among physiology-based approaches, only fractional flow reserve demonstrated clear superiority over angiography guidance. The findings support current guideline recommendations for using advanced guidance techniques in PCI, particularly IVUS, which showed consistent benefits across both acute and stable coronary syndromes. For Australian interventional cardiologists, this evidence reinforces the value of investing in intravascular imaging capabilities and training, as these technologies are increasingly accessible and PBS-supported in appropriate clinical contexts.

Evidence: Strong

Key Findings

  • P Value: Not explicitly reported, but confidence intervals exclude 1.0 indicating statistical significance

  • Effect Size: IVUS-guided PCI: HR 0.69; OCT/OFDI-guided PCI: HR 0.75; FFR-guided PCI: HR 0.81 versus angiography-guided PCI

  • Primary Outcome: Trial-defined major adverse cardiovascular events (MACE)

  • Nnt Or Sensitivity: Approximately 31% reduction in MACE risk with IVUS guidance, 25% with OCT/OFDI, and 19% with FFR compared to angiography guidance

  • Confidence Interval: IVUS: 95% CI 0.60-0.79; OCT/OFDI: 95% CI 0.63-0.90; FFR: 95% CI 0.70-0.95

Clinical Application

IVUS and OCT require additional equipment and expertise but are increasingly available in Australian catheter laboratories. FFR requires pressure wire technology and adenosine administration Aligns with CSANZ guidelines supporting physiology and imaging-guided PCI. PBS covers IVUS and FFR in appropriate clinical scenarios. TGA-approved devices widely available in major centres Patients undergoing PCI for coronary artery disease in both acute and stable presentations, particularly those with complex lesions where guidance modalities are most beneficial

Abstract

BACKGROUND: Despite current guidelines recommending physiology- and intravascular imaging-guided percutaneous coronary intervention (PCI) in specific lesion subsets, angiography-guided PCI remains common in practice. The comparative effectiveness of these strategies remains uncertain. We aimed to compare clinical outcomes of PCI guided by intravascular imaging or physiological assessment versus conventional angiography. METHODS: We conducted a systematic review and network meta-analysis of randomized controlled trials, searching PubMed and EMBASE up to May 31, 2025. Eligible studies compared at least 2 of the following 6 guidance modalities in PCI: angiography, intravascular ultrasound (IVUS), optical coherence tomography/optical frequency domain imaging, fractional flow reserve, angiography-derived fractional flow reserve, and instantaneous wave-free ratio. The primary outcome was trial-defined major adverse cardiovascular events (MACEs). Hazard ratios (HRs) with 95% CIs were pooled using a frequentist random-effects network meta-analysis. Subgroup analyses assessed clinical presentation and guidance objectives such as decision making and procedural optimization. RESULTS: We identified 43 randomized controlled trials involving 39 291 patients. IVUS-guided PCI (HR, 0.69 [95% CI, 0.60-0.79]), optical coherence tomography/optical frequency domain imaging-guided PCI (HR, 0.75 [95% CI, 0.63-0.90]), and fractional flow reserve-guided PCI (HR, 0.81 [95% CI, 0.70-0.95]) were associated with a lower risk of MACEs compared with angiography-guided PCI. Furthermore, IVUS-guided PCI was associated with a lower risk of MACEs compared with instantaneous wave-free ratio-guided PCI (HR, 0.74 [95% CI, 0.55-1.00]). IVUS-guided PCI reduced the risk of MACE in both acute coronary syndrome and non-acute coronary syndrome patients. CONCLUSIONS: IVUS- and optical coherence tomography/optical frequency domain imaging-guided PCI were superior to angiography-guided PCI in reducing MACEs. Among the physiology-based approaches, only fractional flow reserve showed a clear benefit.

References

  1. 1.Saito, T., Aikawa, T., Kiyohara, Y., Ueyama, H. A., Takagi, H., Wiley, J., Secemsky, E. A., Yeh, R. W., Laham, R., Maehara, A., & Kuno, T. (2026). Comparison of intravascular imaging-, physiology-, or angiography-guided approaches for percutaneous coronary intervention: A systematic review and network meta-analysis. Journal of the American Heart Association, 15(7), e046367. https://doi.org/10.1161/JAHA.125.046367
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service